Provided by Tiger Fintech (Singapore) Pte. Ltd.

Catalyst Pharmaceuticals

21.05
+0.09500.45%
Volume:685.07K
Turnover:14.36M
Market Cap:2.57B
PE:13.42
High:21.37
Open:21.10
Low:20.71
Close:20.95
Loading ...

Catalyst Pharmaceuticals Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
Yesterday

Catalyst Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
11 Jul

Catalyst Pharmaceuticals Inc. Stock Rises 4.2%, Outperforms Competitors

Dow Jones
·
10 Jul

Catalyst Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
08 Jul

Catalyst Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
03 Jul

Catalyst Pharmaceuticals Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
02 Jul

Catalyst Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
27 Jun

Catalyst Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
24 Jun

Catalyst Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
21 Jun

Catalyst Pharmaceuticals Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
18 Jun

Chief Strategy Officer Preethi Sundaram Reports Disposal of Common Shares in Catalyst Pharmaceuticals Inc

Reuters
·
13 Jun

Catalyst Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
12 Jun

Catalyst Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
11 Jun

Patrick J. McEnany, Chairman of Board of Directors, Reports Disposal of Common Shares of Catalyst Pharmaceuticals Inc

Reuters
·
11 Jun

Catalyst Pharmaceuticals Inc. Files Initial Statement of Beneficial Ownership for William T. Andrews, Chief Medical Officer

Reuters
·
07 Jun

Catalyst Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
05 Jun

Catalyst Pharmaceuticals CEO Daly buys 70,000 common shares

TIPRANKS
·
04 Jun

Richard J. Daly, President and CEO of Catalyst Pharmaceuticals, Reports Disposal of Common Shares

Reuters
·
04 Jun

Catalyst Pharmaceuticals Announces Appointment of William T. Andrews, Md, Facp as Chief Medical Officer

THOMSON REUTERS
·
02 Jun

Press Release: Catalyst Pharmaceuticals Announces Appointment of William T. Andrews, MD, FACP as Chief Medical Officer

Dow Jones
·
02 Jun